New drug duo targets hard-to-treat stomach cancer
Disease control
Recruiting now
This study tests whether two drugs, avutometinib and defactinib, can shrink tumors and help people with a certain type of advanced stomach cancer live longer. It is for adults whose cancer has spread and who have already tried at least one other treatment. The study will track ho…
Phase: PHASE2 • Sponsor: Ryan H. Moy, MD, PhD • Aim: Disease control
Last updated May 16, 2026 22:41 UTC